2013-01-07 14:44:03 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to produce reports on a company's attractiveness to long-term investors.

Ilhavo, Portugal — SADIF Investment Analytics, announces a new summary due diligence report covering the following companies:

Report Summary for: Biogas Nord AG is a high quality company with a neutral outlook. Biogas Nord AG has strong business growth and is run by efficient management. The trend in Biogas Nord AG fair value exchange rate against its closest rated-competitor, Alphaform AG, has been depreciating over the past 2 weeks. When compared to its closest competitor, Biogas Nord AG shows similar undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-39-BG8

Report Summary for: Biotest AG is a below average

quality company with a neutral outlook. Biotest AG has strong business growth and is run by efficient management. The trend in Biotest AG fair value exchange rate against its closest rated-competitor, Mologen AG, has been depreciating over the past 2 weeks. When compared to its closest competitor, Biotest AG shows greater overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-39-BIO

Report Summary for: Deutsche Technologie Beteiligungen AG is a low quality company with a neutral outlook. Deutsche Technologie Beteiligungen AG has weak business growth and is run by mediocre management. The trend in Deutsche Technologie Beteiligungen AG fair value exchange rate against its closest rated-competitor, bmp media investors AG, has been depreciating over the past 2 weeks. When compared to its closest competitor, Deutsche Technologie Beteiligungen AG shows greater undervaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-39-DTK

Report Summary for: Hypoport AG is an average quality company with a neutral outlook. Hypoport AG has strong business growth and is run by efficient management. The trend in Hypoport AG fair value exchange rate against its closest rated-competitor, Baader Bank AG, has been depreciating over the past 2 weeks. When compared to its closest competitor, Hypoport AG shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-39-HYQ

Report Summary for: InVision AG is a low quality company with a neutral outlook. InVision AG has medium business growth and is run by inefficient management. The trend in InVision AG fair value exchange rate against its closest rated-competitor, Realtech AG, has been depreciating over the past 2 weeks. When compared to its closest competitor, InVision AG shows greater undervaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-39-IVX

Report Summary for: MeVis Medical Solutions AG is a low quality company with a neutral outlook. MeVis Medical Solutions AG has medium business growth and is run by mediocre management. The trend in MeVis Medical Solutions AG fair value exchange rate against its closest rated-competitor, Draegerwerk AG & Co. KGaA, has been appreciating over the past 2 weeks. When compared to its closest competitor, MeVis Medical Solutions AG shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-39-M3V

Report Summary for: Nordex SE is an average quality company with a neutral outlook. Nordex SE has weak business growth and is run by mediocre management. The trend in Nordex SE fair value exchange rate against its closest rated-competitor, VTG AG, has been depreciating over the past 2 weeks. When compared to its closest competitor, Nordex SE shows similar undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-39-NDX1


About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering twenty four different markets and over 18,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.